Abstract
People receiving alcohol and other drug treatment have high tobacco smoking rates and low quit rates. Vaporized nicotine products may be a potential quit smoking strategy for persons receiving drug and alcohol treatment. There are two identified methods for quitting smoking, the first is gradual cessation, which involves reducing the number of cigarettes over a set period of time before complete abstinence, while the second, abrupt, involves setting a quit date and stopping on that date. The feasibility of using a pharmacological strategy, such as an VNP in conjunction with a cessation strategy in combination, is yet to be examined...
Original language | English |
---|---|
Article number | PP25 |
Pages (from-to) | 37-38 |
Number of pages | 2 |
Journal | Asia-Pacific Journal of Clinical Oncology |
Volume | 16 |
Issue number | S6 |
DOIs | |
Publication status | Published - Nov 2020 |
Externally published | Yes |
Event | 2020 Hunter Cancer Research Symposium - Newcastle City Hall, Newcastle, Australia Duration: 6 Nov 2020 → 6 Nov 2020 |
Keywords
- smoking cessation
- electronic nicotine devices
- Vaporized nicotine products